| Demand visibility | Targeting global markets across India, US, MENA, and SEA. |
|---|---|
| Management confidence | High regarding ecosystem integration and global scalability. |
Growth
No Q1 FY27 financial numbers or year-on-year growth percentages provided for Revenue or PAT.
Outlook
Focus on Made-in-India MRI (2025), scaling AI screening platforms globally, and hospital digitization.
Risks
Regulatory framework changes, technology cycles, market fluctuations, and potential inaccuracies in preliminary estimates.
Last quarter's promises, checked
Delivered
- Guided H1 FY26 revenue 120% growth → delivered INR 110cr (+120% YoY) (= BEAT)
- Guided H1 FY26 EBITDA margin expansion → delivered 25% margin (22x YoY growth) (= BEAT)
- Guided Q2 FY26 PAT growth → delivered INR 14cr (vs 0.3cr YoY) (= BEAT)
Partly delivered
- Guided commercial Nanomedic deployment in Nov 2025 → awaiting final CDSCO approval (= PARTIAL)
Investor Presentation filed with BSE, NSE: FISCHER. Summary written with AI assistance from the document.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹34.29
- Market cap
- ₹2,375 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 79.7×Sector 37.5×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 5.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Annual Report
The company issued a corrigendum to its FY 2025-26 Annual Report. This update corrects financial highlights, auditor report details, and capital management tables.
Fischer Medical Ventures Acquisition Worth ₹49.88 Cr
Fischer Medical Ventures will invest ₹49.88 Crore into its three material wholly-owned subsidiaries via rights issues to support capital expansion.
- Value
- ₹49.88 Cr
Fischer Medical Ventures Business Update
Fischer Medical Ventures published a Chairman's Letter outlining its Radiology, Preventive Healthcare and Wellness segments plus Indonesia and Philippines deployments. No new transaction, order or capital event is announced.
Fischer Medical Ventures Annual Report
Fischer Medical Ventures Limited has submitted its Annual Report for the financial year 2025-2026 as per SEBI regulations. The document is available on the company website.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited has scheduled its 33rd Annual General Meeting on September 29, 2026, through video conferencing. The company also announced the e-voting and book closure dates.
Fischer Medical Ventures Investor Presentation: Key Takeaways
Fischer Medical Ventures is building an AI-enabled healthcare platform integrating medical imaging, screening, and hospital digitization. Strategy focuses on vertically integrated IP across magnets, coils, and AI diagnostics.